1. Netherlands Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
IMCD N.V.

IMCD N.V.

IMCD.AS
IMCD N.V.NL flagEuronext Amsterdam
85.08
EUR
+1.58
- -
5.02BMarket Cap
IMCD N.V.
IMCD.AS
(Euronext Amsterdam)

Recent

price

85.08

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
43.02
55.83
61.67
54.08
29.64
32.67
36.38
45.38
51.26
51.63
60.33
80.83
78.05
82.63
- -
Revenue per Share
-1.51
-0.89
-0.27
0.79
1.2
1.39
1.47
1.91
2.06
2.23
3.64
5.5
5.13
4.86
- -
Basic EPS, GAAP
0.73
1.53
0.1
1.29
1.48
1.79
1.93
1.94
2.98
3.98
3.12
4.88
6.72
4.42
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
0.19
0.44
0.55
0.62
0.8
0.88
1.02
1.62
2.37
2.23
- -
Dividend per Share
-1.51
-2.4
-2.67
-1.02
0.52
1.46
2.38
3.63
4.87
6.03
8.29
12.12
13.59
16.12
- -
Book Value per Share
-31.74
-33.68
-36.9
-5.35
-4.91
-3.53
-4.19
-4.83
-5.24
-5.48
-6.09
-4.7
-9.38
-6.88
- -
Tangible Book Value per Share
20
20
20
25
52
52
52
52
52
54
57
57
57
57
- -
Basic Weighted Avg Shares
860
1,117
1,233
1,358
1,530
1,714
1,907
2,379
2,690
2,775
3,435
4,601
4,443
4,728
4,779
Sales/Revenue/Turnover
4.33
6.25
5.95
6.06
6.51
6.72
6.56
6.88
6.71
7.02
8.89
10.03
9.65
8.99
7.77
Operating Margin (%)
26
19
22
23
38
42
39
43
66
73
93
111
114
137
143
Depreciation Expense
-30
-18
-5
20
62
73
77
100
108
120
207
313
292
278
218
Net Income, GAAP
- -
- -
165.84
19.67
20.57
23.01
29.75
28.12
27.68
27.01
26.99
28.19
27.5
26.78
25.29
Effective Tax Rate (%)
-3.52
-1.6
-0.44
1.47
4.04
4.26
4.05
4.21
4.02
4.33
6.03
6.8
6.58
5.89
4.55
Profit Margin (%)
113
1
147
215
199
234
192
270
266
298
339
656
729
1,023
760
Working Capital
679
605
820
302
408
383
367
481
566
390
392
913
1,168
1,368
1,365
LT Debt
-28
-50
-67
531
654
722
729
786
867
1,252
1,461
1,673
1,726
2,215
2,042
Total Equity
- -
- -
-6.45
8.04
8.17
8.04
7.84
9.75
9.4
8.75
12.11
14.38
10.97
8.99
7.14
Return on Invested Capital (%)
- -
- -
-6.42
12.02
19.81
18.47
18.23
20.1
16.59
16.37
26.06
26.14
18.09
14.45
10.08
Return on Capital (%)
- -
- -
- -
- -
- -
141.27
76.66
63.45
48.42
41.43
52.05
53.87
39.94
32.81
22.49
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.89%
10.97%
-7.81%
Free Cash Flow
18.49%
12.53%
19.47%
Net Income, GAAP
16.29%
18.07%
-21.8%
Sales/Revenue/Turnover
12.61%
12.36%
1.08%
Total Cash Common Dividend
33.24%
24.39%
-0.49%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
4,443
2024
- -
- -
- -
- -
4,728
2025
- -
- -
- -
- -
4,779

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
5.13
2024
- -
- -
- -
- -
4.86
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
2.37
2024
- -
- -
- -
- -
2.23
2025
- -
- -
- -
- -
- -
Similar Companies
Zeon Corporation (4205.T)
Lianhe Chemical Technology Co., Ltd. (002250.SZ)
Jubilant Ingrevia Limited (JUBLINGREA.BO)
Jilin OLED Material Tech Co., Ltd. (688378.SS)
China Boton Group Company Limited (3318.HK)
Linde plc (LIN)
Business
IMCD N.V. is a global leader in the distribution and formulation of specialty chemicals and ingredients. Headquartered in Rotterdam, the Netherlands, and founded in 1995, the company operates in over 60 countries across Europe, the Middle East, Africa, North America, South America, and Asia-Pacific, serving industries including pharmaceuticals, beauty and personal care, food and nutrition, advanced materials, coatings and construction, home care and industrial, lubricants and energy, and industrial solutions. IMCD provides market-focused technical expertise, formulation services, and value-added solutions such as repacking, dilution, and blending through its network of 110 offices, 80 laboratories, and 150 warehouses worldwide; its core product portfolio encompasses specialty chemicals like surfactants, polymers, esters, dyes, pigments, monomers, intermediates, building blocks, processing aids, reactive diluants, solvents, additives, and surface active agents for coatings, adhesives, plastics, agrochemicals, lubricants, and fuel additives; pharmaceutical ingredients including active pharmaceutical ingredients, excipients, and intermediates; food and nutrition ingredients and additives; beauty and personal care components; and advanced materials for diverse applications in automotive, industrial, oil and gas, textiles, water treatment, and electronics. In the past two years, IMCD has pursued aggressive growth through multiple strategic acquisitions, completing six in the first nine months of 2025 alone, including TECOM Ingredients S.A. in Iberia for food and beverage enhancement, Trichem Healthcare in India to bolster pharmaceutical supply chains in India and the Middle East, Tillmanns in Italy for expanded industrial, water, and food market presence, Ferrer Alimentación in Iberia to accelerate food and beverage capabilities, Dong Yang FT in South Korea for beauty and personal care strengthening, and others such as YCAM, Daoqin, Selechimica, and prior 2024 deals like CJ Shah, Euro-Chemopharma, Biofresh, Reschem, and Guangzhou RBD Chemical, collectively adding approximately EUR 340 million in annualized revenues and 185 employees. These moves, alongside the establishment of an Innovation Lab in 2024 and over EUR 5 million in R&D investment in 2023 yielding more than 30 new eco-friendly product lines for 2025 launches, underscore IMCD's commitment to scaling operations, enhancing regional footprints, and driving innovation in sustainable solutions.